The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

In this article, we are going to take a look at where Salesforce ... shared the reasons behind his approval. "Well, I think that, in the end, he respects the process. I think a lot of the ...

We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against ...

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double digits. Investor enthusiasm about technology and growth stocks, and the ...

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double digits. Investor enthusiasm about technology and growth stocks, and the ...

Accurate invoicing for professional services organisations can be a challenge. Rocketlane has launched a new invoicing solution that aims to improve ...

A major tech employer with thousands of workers in Massachusetts will effectively end hybrid work as of March 3.

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...